insiderwall
Menu
SuperinvestorInsider
10x Genomics Inc. TXG

Super Investor & Insider

Nessuna transazione insider negli ultimi 6 mesi.

Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.

About

10x Genomics develops and sells instruments, consumables, and software for analyzing biological systems globally. The company specializes in single cell and spatial biology, enabling researchers to study individual cells and understand complex biological processes at unprecedented resolution. Its primary platforms incl

SectorHealthcare
ExchangeNASDAQ
IndustryHealth Information Services
CountryUnited States
Employees1,306
TickerTXG

Statistics

Market Cap$4.14B
Revenue (TTM)$642.8M
Net Income-$43.5M
Net Margin-6.8%
EPS$-0.17
P/E-83.00
P/S5.80
P/B4.68
EV/EBITDA-111.68
ROE-3.0%
Dividend Yield
Price$32.09

Data: Twelve Data · Revenue = mcap / P/S